搜尋
Baxter International Inc
BAX添加自選
17.530USD
-0.460-2.56%
收盤 05/11, 16:00（美東）報價延遲15分鐘
9.05B總市值
虧損本益比TTM
關於 Baxter International Inc 公司
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Inc簡介
公司代碼BAX
公司名稱Baxter International Inc
上市日期Jun 20, 2097
CEOHider (Andrew P)
員工數量38000
證券類型Ordinary Share
年結日Jun 20
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編60015
電話12249482000
網址https://www.baxter.com/
公司代碼BAX
上市日期Jun 20, 2097
CEOHider (Andrew P)
Baxter International Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+43.66%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
16.05K
-42.89%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.82K
+1.52%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
8.08K
+1.40%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
204.00K
-80.42%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-0.46%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
107.69K
-7.39%
Mr. Reazur Rasul
Mr. Reazur Rasul
Executive Vice President, Group President - Healthcare Systems and Technologies
Executive Vice President, Group President - Healthcare Systems and Technologies
78.91K
-18.11%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
36.34K
+1.75%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+23.76%
收入明細
單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
其他
1.52B
13.54%
地區USD
名稱
營收
佔比
United States
6.12B
54.45%
International
5.12B
45.55%
業務
地區
業務USD
名稱
營收
佔比
Infusion Therapies and Technologies
4.10B
36.47%
Care and Connectivity Solutions
1.91B
17.00%
Injectables and Anesthesia
1.35B
12.02%
Advanced Surgery
1.20B
10.65%
Front Line Care
1.16B
10.32%
其他
1.52B
13.54%
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Pzena Investment Management, LLC
12.49%
Dodge & Cox
11.04%
Vanguard Capital Management, LLC
6.49%
BlackRock Institutional Trust Company, N.A.
6.30%
BlackRock Financial Management, Inc.
5.88%
其他
57.80%
持股股東
持股股東
佔比
Pzena Investment Management, LLC
12.49%
Dodge & Cox
11.04%
Vanguard Capital Management, LLC
6.49%
BlackRock Institutional Trust Company, N.A.
6.30%
BlackRock Financial Management, Inc.
5.88%
其他
57.80%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
50.99%
Investment Advisor
47.08%
Research Firm
2.40%
Hedge Fund
2.12%
Insurance Company
1.43%
Pension Fund
1.30%
Sovereign Wealth Fund
1.22%
Bank and Trust
0.83%
Private Equity
0.40%
機構持股
更新時間: 4月5日 週日
更新時間: 4月5日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
1767
557.84M
108.01%
-45.35M
2025Q4
1743
527.76M
108.76%
+72.60K
2025Q3
1826
527.84M
110.04%
+1.85M
2025Q2
1880
509.50M
105.73%
+4.72M
2025Q1
1916
504.93M
105.92%
-38.38M
2024Q4
1965
494.73M
105.04%
+14.02M
2024Q3
1980
482.92M
103.29%
+12.67M
2024Q2
2019
470.33M
102.19%
-1.85M
2024Q1
2069
469.00M
102.47%
-52.95M
2023Q4
2111
469.21M
101.33%
+9.34M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Pzena Investment Management, LLC
70.05M
13.57%
+12.66M
+22.06%
Dec 31, 2025
Dodge & Cox
57.00M
11.04%
-396.40K
-0.69%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
32.56M
6.31%
+1.24M
+3.96%
Dec 31, 2025
BlackRock Financial Management, Inc.
30.37M
5.88%
+5.68M
+23.02%
Dec 31, 2025
Fidelity Management & Research Company LLC
29.38M
5.69%
+17.44M
+146.19%
Dec 31, 2025
State Street Investment Management (US)
22.54M
4.37%
+542.01K
+2.46%
Dec 31, 2025
Greenhaven Associates, Inc.
10.69M
2.07%
+4.40M
+70.05%
Dec 31, 2025
Geode Capital Management, L.L.C.
13.51M
2.62%
+972.89K
+7.76%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Large Cap Value Active ETF
2.23%
First Trust Indxx Medical Devices ETF
1.69%
Invesco Raymond James SB-1 Equity ETF
1.5%
State Street SPDR S&P Health Care Equipment ETF
1.37%
Invesco S&P 500 Equal Weight Health Care ETF
1.26%
Franklin US Dividend Booster Index ETF
1.26%
iShares U.S. Medical Devices ETF
1.13%
Invesco Zacks Multi-Asset Income ETF
0.8%
Humankind US Stock ETF
0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.57%
查看更多
iShares Large Cap Value Active ETF
佔比2.23%
First Trust Indxx Medical Devices ETF
佔比1.69%
Invesco Raymond James SB-1 Equity ETF
佔比1.5%
State Street SPDR S&P Health Care Equipment ETF
佔比1.37%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.26%
Franklin US Dividend Booster Index ETF
佔比1.26%
iShares U.S. Medical Devices ETF
佔比1.13%
Invesco Zacks Multi-Asset Income ETF
佔比0.8%
Humankind US Stock ETF
佔比0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
佔比0.57%
分紅派息
近5年累計派現
2.28B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Apr 29, 2026
BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Jul 01, 2026 going ex on May 29, 2026
May 29, 2026
Jul 01, 2026
May 29, 2026
Feb 12, 2026
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026
Feb 27, 2026
Apr 01, 2026
Feb 27, 2026
Feb 12, 2026
BAX.NB Interim Cash Dividend of gross USD 0.01 paid on Apr 01, 2026 going ex on Feb 27, 2026 with reinvestment option
Feb 27, 2026
Apr 01, 2026
Feb 27, 2026
Nov 11, 2025
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option
Nov 28, 2025
Jan 02, 2026
Nov 28, 2025
Jul 14, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option
Aug 29, 2025
Oct 01, 2025
Aug 29, 2025
May 06, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option
May 30, 2025
Jul 01, 2025
May 30, 2025
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
查看更多
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
